Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transcranial magnetic stimulation for treating depression.

J L Martin1, M J Barbanoj, T E Schlaepfer

  • 1Iberoamerican Cochrane Centre, Department of Epidemiology, Hospital de la Santa Creu i Sant Pau, Sant Antoni M feminine Claret, 171, Barcelona, Catalunya, Spain, 08041. jrodriguezma@hsp.santpau.es

The Cochrane Database of Systematic Reviews
|June 22, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cognitive and behavioral disturbances in PSP and MSA: clinical features and imaging correlates.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same author

The discriminative linguistic profiles of progressive supranuclear palsy and Parkinson's disease.

Neurologia·2025
Same author

SYNAPSES. A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: post-hoc analysis of the Spanish study population.

Revista de neurologia·2023
Same author

[Essential tremor: are we just splitting hairs? Non-motor symptoms and essential tremor-plus].

Revista de neurologia·2023
Same author

Pharmacological management of Parkinson's disease motor symptoms: update and recommendations from an expert.

Revista de neurologia·2022
Same author

Staging Parkinson's Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of Life.

Parkinson's disease·2021

Repetitive transcranial magnetic stimulation (rTMS) shows limited evidence for treating depression. While some specific applications favored rTMS, overall results indicate no significant benefit compared to sham treatments.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Clinical Trials

Background:

  • Transcranial magnetic stimulation (TMS) uses magnetic pulses to excite or inhibit brain cortical areas.
  • High-frequency TMS typically excites, while low-frequency TMS inhibits brain activity.
  • TMS has been explored as a potential therapeutic intervention for depression.

Purpose of the Study:

  • To systematically evaluate the clinical effectiveness and safety of TMS for treating depressive disorders.
  • To synthesize findings from randomized controlled trials (RCTs) investigating TMS in depression.

Main Methods:

  • A comprehensive literature search was conducted across multiple databases (e.g., Cochrane, MEDLINE, EMBASE) up to June 2001.
  • Included randomized controlled trials assessing the efficacy and safety of TMS for depression.

Related Experiment Videos

  • Data extraction and verification were performed independently by reviewers, with disagreements resolved through discussion.

    • Main Results:

    • Sixteen trials were reviewed; fourteen provided data for quantitative analysis.
    • No significant differences were observed between repetitive TMS (rTMS) and sham TMS on depression rating scales, with minor exceptions.
    • Electroconvulsive therapy (ECT) showed greater efficacy than rTMS in psychotic patients after two weeks, based on the Hamilton Depression Rating Scale.

    Conclusions:

    • Current evidence does not strongly support the use of TMS as a beneficial treatment for depression.
    • Small sample sizes in some studies do not entirely rule out potential benefits.
    • Further research may be needed to clarify the role of TMS in depression management.